DSpace at RU >

Search Results

Results 1-50 of 67.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2012	Identification of Mycobacterium tuberculosis complex by polymerase chain reaction of Exact Tandem Repeat-D fragment from mycobacterial cultures.	Coitinho, C.; Greif, G.; Robello, C.; Ingen, J. van; Rivas, C.
	2012	On the road to unravelling the aetiology of non-tuberculous mycobacterial disease [Editorial]	Soolingen, D. van; Ingen, J. van
	2012	No human transmission of Mycobacterium malmoense in a perfect storm setting	Hoefsloot, W.; Boeree, M.J.; van Nieuwkoop, C.; Bernards, A.T.; Savelkoul, P.H.; van Ingen, J.; van Soolingen, D.
	2012	Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies.	Ingen, J. van; Rahim, Z.; Mulder, A.; Boeree, M.J.; Simeone, R.; Brosch, R.; Soolingen, D. van
	2012	Hypersensitivity pneumonitis caused by Mycobacterium avium subsp. hominissuis in a hot tub, as proven by IS1245 RFLP and rep-PCR typing	van der Zanden, R.; Magis-Escurra Ibanez, C.; Lange, W.C.M. de; Hoefsloot, W.; Boeree, M.J.; Ingen, J. van; Soolingen, D. van
	2012	Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates in Uruguay	Greif, G.; Coitinho, C.; Rivas, C.; Ingen, J. van; Robello, C.
	2012	Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.	Ingen, J. van; Boeree, M.J.; Soolingen, D. van; Mouton, J.W.
	2012	Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?	Ingen, J. van; Boeree, M.J.; Soolingen, D. van; Iseman, M.D.; Heifets, L.B.; Daley, C.L.
	2012	ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria.	Houben, D.; Demangel, C.; Ingen, J. van; Perez, J.; Baldeon, L.; Abdallah, A.M.; Caleechurn, L.; Bottai, D.; Zon, M. van; Punder, K. de; Laan, T. van der; Kant, A.; Bossers-de Vries, R.; Willemsen, P.; Bitter, W.; Soolingen, D. van; Brosch, R.; Wel, N. van der; Peters, P.J.H.
	2012	Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study	Verregghen, M.; Heijerman, H.G.; Reijers, M.; Ingen, J. van; van der Ent, C.K.
	2012	Characterization of a novel variant of Mycobacterium chimaera.	Ingen, J. van; Hoefsloot, W.; Buijtels, P.C.; Tortoli, E.; Supply, P.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van
	2012	In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease	Ingen, J. van; Totten, S.E.; Helstrom, N.K.; Heifets, L.B.; Boeree, M.J.; Daley, C.L.
	2012	The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment	Ingen, J. van; Egelund, E.F.; Levin, A.; Totten, S.E.; Boeree, M.J.; Mouton, J.W.; Aarnoutse, R.E.; Heifets, L.B.; Peloquin, C.A.; Daley, C.L.
	2012	Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.	Simons, S.O.; Ingen, J. van; Laan, T. van der; Mulder, A.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van
	2012	Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease.	Ingen, J. van; Totten, S.E.; Heifets, L.B.; Boeree, M.J.; Daley, C.L.
	2011	Strategies to improve outcome of drug treatment for Mycobacterium abscessus pulmonary disease.	Ingen, J. van
	2011	Cervicofacial lymphadenitis caused by nontuberculous mycobacteria; host, environmental or bacterial factors?	Ingen, J. van; Soolingen, D. van
	2011	XDR tuberculosis	Ingen, J. van; Lange, W.C.M. de; Boeree, M.J.; Iseman, M.D.; Daley, C.L.; Heifets, L.B.; Bottger, E.C.; Soolingen, D. van
	2011	"Mycobacterium tilburgii" Infection in Two Immunocompromised Children: Importance of Molecular Tools in Culture-Negative Mycobacterial Disease Diagnosis	Hartwig, N.G.; Warris, A.; Vosse, E. van de; Zanden, A.G. van der; Schulin-Casonato, T.; Ingen, J. van; Hest, R. van
	2011	Xpert MTB/RIF(R), a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis	Bowles, E.C.; Freyee, B.; van Ingen, J.; Mulder, B.; Boeree, M.J.; van Soolingen, D.
	2011	Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge	Ingen, J. van; Aarnoutse, R.E.; Vries, G. de; Boeree, M.J.; Soolingen, D. van
	2011	Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?	Ingen, J. van; Aarnoutse, R.E.; Donald, P.R.; Diacon, A.H.; Dawson, R.; Plemper van Balen, G.; Gillespie, S.H.; Boeree, M.J.
	2011	Nontuberculous mycobacteria in respiratory tract infections, eastern Asia	Simons, S.O.; Ingen, J. van; Hsueh, P.R.; Hung, N. Van; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van
	2011	The broad-spectrum antimycobacterial activities of phenothiazines, InVitro: somewhere in all of this there may be patentable potentials.	Ingen, J. van
	2011	Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007	Majoor, C.J.; Magis-Escurra Ibanez, C.; Ingen, J. van; Boeree, M.J.; Soolingen, D. van
	2011	Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species	Ingen, J. van; Tortoli, E.; Selvarangan, R.; Coyle, M.B.; Crump, J.A.; Morrissey, A.B.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van
	2011	Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania	Boogaard, J. van den; Semvua, H.H.; Ingen, J. van; Mwaigwisya, S.; Laan, T. van der; Soolingen, D. van; Kibiki, G.S.; Boeree, M.J.; Aarnoutse, R.E.
	2010	Disseminated Mycobacterium avium subsp. avium infection in a cat, the Netherlands.	Groot, P.H.; Ingen, J. van; Zwaan, R. de; Mulder, A.; Boeree, M.J.; Soolingen, D. van
	2010	Otomastoiditis caused by Mycobacterium abscessus, The Netherlands.	Ingen, J. van; Looijmans, F.; Mirck, P.; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van
	2010	Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999-2007.	Ingen, J. van; Zwaan, R. de; Enaimi, M.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van
	2010	Microevolution of Mycobacterium tuberculosis in a tuberculosis patient.	Al-Hajoj, S.A.; Akkerman, O.; Parwati, I.; al-Gamdi, S.; Rahim, Z.; Soolingen, D. van; Ingen, J. van; Supply, P.; Zanden, A.G. van der
	2010	Rapidly growing nontuberculous mycobacteria cultured from home tap and shower water.	Ingen, J. van; Blaak, H.; Beer, J. de; Roda Husman, A.M. de; Soolingen, D. van
	2010	Multiple strains of Mycobacterium avium subspecies hominissuis infections associated with aborted fetuses and wasting in pigs.	Wellenberg, G.J.; Haas, P.E. de; Ingen, J. van; Soolingen, D. van; Visser, I.J.
	2010	Isolation of mycobacteria other than Mycobacterium avium from porcine lymph nodes.	Ingen, J. van; Wisselink, H.J.; Solt-Smits, C.B. van; Boeree, M.J.; Soolingen, D. van
	2010	The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.	Soolingen, D. van; Hernandez-Pando, R.; Orozco, H.; Aguilar, D.; Magis-Escurra Ibanez, C.; Amaral, L.; Ingen, J. van; Boeree, M.J.
	2010	Application of modern microbiological diagnostic methods for tuberculosis in Macha, Zambia.	Verweij, K.E.; Kamerik, A.R.; Ingen, J. van; Dijk, J.H. van; Sikwangala, P.; Thuma, P.; Nouwen, J.L.; Soolingen, D. van
	2010	Surgical treatment of non-tuberculous mycobacterial lung disease: strike in time.	Ingen, J. van; Verhagen, A.F.T.M.; Dekhuijzen, P.N.R.; Soolingen, D. van; Magis-Escurra Ibanez, C.; Boeree, M.J.; Lange, W.C.M. de
	2010	In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.	Ingen, J. van; Laan, T. van der; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van
	2010	The changing pattern of clinical Mycobacterium avium isolation in the Netherlands.	Ingen, J. van; Hoefsloot, W.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van
	2010	Nontuberculeuze mycobacteriën : klinisch relevant	Ingen, J. van; Hoefsloot, W.; Lange, W.C.M. de; Magis-Escurra Ibanez, C.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van
	2010	Molecular characteristics of "Mycobacterium canettii" the smooth Mycobacterium tuberculosis bacilli.	Fabre, M.; Hauck, Y.; Soler, C.; Koeck, J.L.; Ingen, J. van; Soolingen, D. van; Vergnaud, G.; Pourcel, C.
	2010	Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.	Ingen, J. van; Simons, S.O.; Zwaan, R. de; Laan, T. van der; Kamst-van Agterveld, M.; Boeree, M.J.; Soolingen, D. van
	2009	Nontuberculous myobacteria: from gene sequences to clinical relevance.	Ingen, J. van
	2009	In vitro activity of thioridazine against mycobacteria.	Ingen, J. van; Laan, T. van der; Amaral, L.; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van
	2009	Clinical relevance of nontuberculous Mycobacteria, Oman.	Al-Mahruqi, S.H.; Ingen, J. van; Al-Busaidy, S.; Boeree, M.J.; Al-Zadjali, S.; Patel, A.; Dekhuijzen, P.N.R.; Soolingen, D. van
	2009	Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character.	Ingen, J. van; Zwaan, R. de; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van
	2009	Mycobacterium riyadhense sp. nov., a non-tuberculous species identified as Mycobacterium tuberculosis complex by a commercial line-probe assay.	Ingen, J. van; Al-Hajoj, S.A.; Boeree, M.J.; Al-Rabiah, F.; Enaimi, M.; Zwaan, R. de; Tortoli, E.; Dekhuijzen, R.; Soolingen, D. van
	2009	Invasive disease caused by nontuberculous mycobacteria, Tanzania.	Crump, J.A.; Ingen, J. van; Morrissey, A.B.; Boeree, M.J.; Mavura, D.R.; Swai, B.; Thielman, N.M.; Bartlett, J.A.; Grossman, H.; Maro, V.P.; Soolingen, D. van
	2009	Mycobacterium insubricum sp. nov.	Tortoli, E.; Baruzzo, S.; Heijdra, Y.F.; Klenk, H.P.; Lauria, S.; Mariottini, A.; Ingen, J. van
	2009	Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov.	Ingen, J. van; Boeree, M.J.; Kosters, K.; Wieland, A.; Tortoli, E.; Dekhuijzen, P.N.R.; Soolingen, D. van

1 2 next